Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
On November 8, 2023, the FDA approved Mounjaro (branded as Zepbound) for chronic weight management in overweight and obese adults with at least one weight-related condition (such as high blood pressure, type 2 diabetes or high cholesterol.) This approval is in addition to a reduced-calorie diet and increased physical activity
At this time, MEDVis GLP-1 compound treatments are not processed through traditional insurance plans
A clear picture of what the program includes, what it does not, and where it falls short compared to alternatives
GLP-1 Mechanism: GLP-1 is a hormone released in the gut after eating
These medications also help control blood sugar levels
US$ 24.91
US$ 27.65
US$ 28.47
US$ 25.72
US$ 21.91
